Cungui Mao

Cungui Mao

Auto-generated profile, based on publicly available information

Cungui Mao

Department of Medicine, Medical University of South Carolina, Charleston, SC 29425, USA

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2008 in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Verified
Journal Article
Closed access
CMCungui Mao
Cungui Mao
LOLina M Obeid
Lina M Obeid

1 July 2001 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
CMCungui Mao
Cungui Mao
RXRuijuan Xu
Ruijuan Xu
ZSZdzislaw M. Szulc
Zdzislaw M. Szulc
ABAlicja Bielawska
Alicja Bielawska
SGSehamuddin H. Galadari
Sehamuddin H. Galadari
LOLina M. Obeid
Lina M. Obeid
Ceramidases are enzymes involved in regulating cellular levels of ceramides, sphingoid bases, and their phosphates. Based on sequence homology to the yeast alkaline ceramidases YPC1p (Mao, C., Xu, R., Bielawska, A., and Obeid, L. M. (2000) J. Biol. Chem. 275, 6876–6884) and YDC1p (Mao, C., Xu, R., Bielawska, A., Szulc, Z. M., and Obeid, L. M. (2000) J. Biol Chem. 275, 31369–31378), we report the identification and cloning of a cDNA encoding for a novel human alkaline ceramidase (aPHC) that hydrolyzes phytoceramide selectively. Northern blot analysis showed that aPHC was ubiquitously expressed, with the highest expression in placenta. Green fluorescent protein tagging showed that it was localized in both the Golgi apparatus and endoplasmic reticulum. Overexpression of aPHC in mammalian cells elevated in vitro ceramidase activity towardN-4-nitrobenz-2-oxa-1,3-diazole-C12-phytoceramide. Its expression in a yeast mutant strain devoid of any ceramidase activity restored the ceramidase activity and caused an increase in the hydrolysis of phytoceramide in yeast cells, thus leading to the decreased biosynthesis of sphingolipids. These data collectively suggest that, similar to the yeast phytoceramidase YPC1p, aPHC has phytoceramidase activity both in vitro and in cells; hence, it is a functional homolog of the yeast phytoceramidase YPC1p. However, in contrast to YPC1p, aPHC exhibited no reverse activity of ceramidase either in vitro or in cells. Biochemical characterization showed that aPHC had a pH optimum of 9.5, was activated by Ca2+, but was inhibited by Zn2+ and sphingosine. Substrate specificity showed that aPHC hydrolyzed phytoceramide preferentially. Together, these data demonstrate that aPHC is a novel human alkaline phytoceramidase, the first mammalian alkaline ceramidase to be identified as being specific for the hydrolysis of phytoceramide.

1 September 2006 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
RXRuijuan Xu
Ruijuan Xu
JJJunfei Jin
Junfei Jin
WHWei Hu
Wei Hu
WSWei Sun
Wei Sun
JBJacek Bielawski
Jacek Bielawski
CMCungui Mao
Cungui Mao
Sphingosine‐1‐phosphate (S1P), a sphingolipid metabolite, promotes cell proliferation and survival whereas its precursor, sphingosine, has the opposite effects. However, much remains unknown about their regulation. Here we identify a novel human ceramidase (haCER2) that regulates the levels of both sphingosine and S1P by controlling the hydrolysis of ceramides. haCER2 is localized to the Golgi complex and is highly expressed in the placenta. High ectopic expression of haCER2 caused fragmentation of the Golgi complex and growth arrest in HeLa cells due to sphingosine accumulation. Low ectopic expression of haCER2 increased S1P without sphingosine accumulation, promoting cell proliferation in serum‐free medium. This proliferative effect was suppressed by dimethylsphingosine, an inhibitor of the S1P formation, or by the RNA interference (RNAi) ‐mediated inhibition of S1P 1, a G‐protein‐coupled receptor for S1P. The RNAi‐mediated down‐regulation of haCER2 enhanced the serum deprivation‐induced growth arrest and apoptosis of HeLa cells, which was inhibited by addition of exogenous S1P. Serum deprivation up‐regulated both haCER2 mRNA and activity in HeLa cells. haCER2 mRNA is also up‐regulated in some tumors. Taken together, these results suggest that haCER2 is important for the generation of S1P and S1P‐mediated cell proliferation and survival, but that its overexpression may cause cell growth arrest due to an accumulation of sphingosine.—Xu, R., Jin, J., Hu, W., Sun, W., Bielawski, J., Szulc, Z., Taha, T., Obeid, L. M., Mao, C. Golgi alkaline ceramidase regulates cell proliferation and survival by controlling levels of sphingosine and S1P FASEB J . 20, 1813–1825 (2006)

1 March 2010 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
WHWei Hu
Wei Hu
RXRuijuan Xu
Ruijuan Xu
WSWei Sun
Wei Sun
ZSZdzislaw M. Szulc
Zdzislaw M. Szulc
JBJacek Bielawski
Jacek Bielawski
CMCungui Mao
Cungui Mao
Ceramides with different fatty acyl chains may vary in their physiological or pathological roles; however, it remains unclear how cellular levels of individual ceramide species are regulated. Here, we demonstrate that our previously cloned human alkaline ceramidase 3 (ACER3) specifically controls the hydrolysis of ceramides carrying unsaturated long acyl chains, unsaturated long-chain (ULC) ceramides. In vitro, ACER3 only hydrolyzed C18:1-, C20:1-, C20:4-ceramides, dihydroceramides, and phytoceramides. In cells, ACER3 overexpression decreased C18:1- and C20:1-ceramides and dihydroceramides, whereas ACER3 knockdown by RNA interference had the opposite effect, suggesting that ACER3 controls the catabolism of ULC ceramides and dihydroceramides. ACER3 knockdown inhibited cell proliferation and up-regulated the cyclin-dependent kinase inhibitor p21CIP1/WAF1. Blocking p21CIP1/WAF1 up-regulation attenuated the inhibitory effect of ACER3 knockdown on cell proliferation, suggesting that ACER3 knockdown inhibits cell proliferation because of p21CIP1/WAF1 up-regulation. ACER3 knockdown inhibited cell apoptosis in response to serum deprivation. ACER3 knockdown up-regulated the expression of the alkaline ceramidase 2 (ACER2), and the ACER2 up-regulation decreased non-ULC ceramide species while increasing both sphingosine and its phosphate. Collectively, these data suggest that ACER3 catalyzes the hydrolysis of ULC ceramides and dihydroceramides and that ACER3 coordinates with ACER2 to regulate cell proliferation and survival.

1 March 2005 in Molecular Biology of the Cell
Verified
Journal Article
Closed access
WHWei Hu
Wei Hu
RXRuijuan Xu
Ruijuan Xu
GZGuofeng Zhang
Guofeng Zhang
JJJunfei Jin
Junfei Jin
ZSZdzislaw M. Szulc
Zdzislaw M. Szulc
CMCungui Mao
Cungui Mao
Ceramide has been shown to cause anoikis, a subtype of apoptosis due to inadequate cell adhesion. However, the underlying mechanism is unclear. Herein, we report that D-e-C6-ceramide (D-e-Cer), via generating sphingosine, disrupts the Golgi complex (GC), which is associated with various cellular effects, including anoikis. Treatment of HeLa cells with D-e-Cer caused cell elongation, spreading inhibition, rounding, and detachment before apoptosis (anoikis). In D-e-Cer–treated cells, glycosylation of β1 integrin in the GC was inhibited, thus its associated integrin receptors failed to translocate to the cell surface. Ceramide treatment also inhibited the reorganization of both microtubule and F-actin cytoskeletons, focal adhesions, and filopodia. These cellular effects were preceded by fragmentation of the Golgi complex. In contrast, L-e-C6-ceramide (L-e-Cer), the enantiomer of D-e-Cer, failed to induce these cellular effects. Mass spectrometric analysis revealed that treatment HeLa cells with D-e-Cer but not L-e-Cer caused a >50-fold increase in the levels of sphingosine, a product of hydrolysis of ceramide. Treatment with D-e-sphingosine and its enantiomer, L-e-sphingosine, caused massive perinuclear vacuolization, Golgi fragmentation, and cell rounding. Together, these results suggest that sphingosine generated from hydrolysis of ceramide causes the GC disruption, leading to various cellular effects.

1 February 2008 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
PDF file
WSWei Sun
Wei Sun
RXRuijuan Xu
Ruijuan Xu
WHWei Hu
Wei Hu
JJJunfei Jin
Junfei Jin
HCHeather A. Crellin
Heather A. Crellin
CMCungui Mao
Cungui Mao